• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
Myocarditis linked to small number of Pfizer recipients in Israel

Myocarditis linked to small number of Pfizer recipients in Israel

The country’s health ministry has observed 275 cases of myocarditis among more than five million vaccinated people.


GPs key to opening up ‘fortress Australia’

GPs key to opening up ‘fortress Australia’

The re-opening of international borders is inevitable, but first GPs need help to combat COVID complacency and vaccine hesitancy.


What is needed to get Australians vaccinated by December?

What is needed to get Australians vaccinated by December?

Completing the vaccination program in 2021 is plausible, but GPs say additional funding and delivering mRNA vaccines will be crucial to utilising general practice’s ‘untapped capacity’.


Mounting evidence suggests COVID vaccines do reduce transmission

Mounting evidence suggests COVID vaccines do reduce transmission

Since vaccines began rolling out across the world, many scientists have been hesitant to say they can reduce transmission of the virus.


Promise wanes for mRNA onshore production

Promise wanes for mRNA onshore production

With local manufacturing of mRNA vaccines looking increasingly slim in the short term, where does that leave Australia?


No evidence that recent blood clot deaths were linked to COVID vaccine

No evidence that recent blood clot deaths were linked to COVID vaccine

The TGA has confirmed there is ‘no likely association’ between the deaths of two NSW men and the AstraZeneca vaccine.


Numbers confirm GPs are the ‘backbone’ of COVID vaccine rollout

Numbers confirm GPs are the ‘backbone’ of COVID vaccine rollout

Australia’s GPs have now administered more than 1.05 million vaccine doses – more than half the rollout’s total of 2.03 million.


Benefits of AstraZeneca overwhelmingly high despite increased clotting risk

Benefits of AstraZeneca overwhelmingly high despite increased clotting risk

New European research has found the risk of a rare blood clotting syndrome associated with the vaccine is double what has been previously reported.


The world wants mRNA vaccines – but we’re short of vital components

The world wants mRNA vaccines – but we’re short of vital components

Given AstraZeneca is no longer recommended for under-50s, Australia is looking to other vaccines to fill the gap.


Are blood clots a concern with mRNA vaccines?

Are blood clots a concern with mRNA vaccines?

An investigation into Australia’s first case of blood clotting after the Pfizer vaccine has yet to confirm a link.


  • Previous
  • ...
  • 7
  • 8
  • 9
  • ...
  • Next
Pages: 7 of 15
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807